DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar Reddragyn (67.23) Submitted: 7/24/2012 11:51:48 PM : Outperform Start Price: $1.09 DRRX Score: -15.07

IMF

Member Avatar Reddragyn (67.23) Submitted: 7/26/2012 5:51:47 PM
Recs: 0

+Top 100

Featured Broker Partners


Advertisement